AAAAAA
Results: 251-265/265
Authors:
RONDINELLI RH
EPNER DE
TRICOLI JV
Citation: Rh. Rondinelli et al., INCREASED GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GENE-EXPRESSION INLATE PATHOLOGICAL STAGE HUMAN PROSTATE-CANCER, PROSTATE CANCER AND PROSTATIC DISEASES, 1(2), 1997, pp. 66-72
Authors:
DEANTONI EP
GOKTAS S
STENNER J
ODONNELL C
CRAWFORD ED
Citation: Ep. Deantoni et al., A CROSS-SECTIONAL STUDY OF VASECTOMY, TIME SINCE VASECTOMY AND PROSTATE-CANCER, PROSTATE CANCER AND PROSTATIC DISEASES, 1(2), 1997, pp. 73-78
Authors:
FENELEY MR
GREEN JSA
YOUNG MPA
BOSE P
KIRBY RS
PEELING WB
PARKINSON MC
Citation: Mr. Feneley et al., PREVALENCE OF PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) IN BIOPSIES FROM HOSPITAL PRACTICE AND PILOT SCREENING - CLINICAL IMPLICATIONS, PROSTATE CANCER AND PROSTATIC DISEASES, 1(2), 1997, pp. 79-83
Authors:
KIRBY R
JARDIN A
Citation: R. Kirby et A. Jardin, DOXAZOSIN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - A REVIEWOF THE SAFETY PROFILE IN OLDER PATIENTS, PROSTATE CANCER AND PROSTATIC DISEASES, 1(2), 1997, pp. 84-89
Authors:
NIXON RG
WENER MH
SMITH KM
PARSON RE
BLASE AB
BRAWER MK
Citation: Rg. Nixon et al., DAY-TO-DAY CHANGES IN FREE AND TOTAL PSA - SIGNIFICANCE OF BIOLOGICALVARIATION, PROSTATE CANCER AND PROSTATIC DISEASES, 1(2), 1997, pp. 90-96
Authors:
LLOYD SN
KAVANAGH J
CHAN PSF
FERREIRA AM
GU FL
PAVONEMACALUSO M
XIA S
BLACKLOCK N
Citation: Sn. Lloyd et al., A MULTICENTER PROSPECTIVE-STUDY OF PROSTATIC VOLUME IN ASYMPTOMATIC MEN IN VARIOUS CONTINENTS, PROSTATE CANCER AND PROSTATIC DISEASES, 1(2), 1997, pp. 97-100
Authors:
KOCH MO
SMITH JA
Citation: Mo. Koch et Ja. Smith, LOW-MOLECULAR-WEIGHT HEPARIN AND RADICAL PROSTATECTOMY - A PROSPECTIVE ANALYSIS OF SAFETY AND SIDE-EFFECTS, PROSTATE CANCER AND PROSTATIC DISEASES, 1(2), 1997, pp. 101-104
Authors:
KIRBY R
SCHER H
BRAWER M
Citation: R. Kirby et al., UNTITLED, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 1-1
Authors:
KIRBY RS
Citation: Rs. Kirby, PRETREATMENT STAGING OF PROSTATE-CANCER - RECENT ADVANCES AND FUTURE-PROSPECTS, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 2-10
Authors:
KIRK D
Citation: D. Kirk, MRC STUDY - WHEN TO COMMENCE TREATMENT IN ADVANCED PROSTATE-CANCER, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 11-15
Authors:
RAJAKOSKI K
PIIRONEN T
PETTERSSON K
LOVGREN J
KARP M
Citation: K. Rajakoski et al., EPITOPE MAPPING OF HUMAN PROSTATE-SPECIFIC ANTIGEN AND GLANDULAR KALLIKREIN EXPRESSED IN INSECT CELLS, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 16-20
Authors:
KOIVISTO P
Citation: P. Koivisto, ANEUPLOIDY AND RAPID CELL-PROLIFERATION IN RECURRENT PROSTATE CANCERSWITH ANDROGEN RECEPTOR GENE AMPLIFICATION, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 21-25
Authors:
BYRNES CA
LISS CL
TENOVER JL
LIPPERT MC
GILLENWATER JY
Citation: Ca. Byrnes et al., COMBINED ANALYSIS OF 2 MULTICENTER STUDIES OF FINASTERIDE 5 MG IN THETREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 26-31
Authors:
ARAKAWA A
SOH S
CHAKRABORTY S
SCARDINO PT
WHEELER TM
Citation: A. Arakawa et al., PROGNOSTIC-SIGNIFICANCE OF ANGIOGENESIS IN CLINICALLY LOCALIZED PROSTATE-CANCER (STAINING FOR FACTOR VIII-RELATED ANTIGEN AND CD34 ANTIGEN), PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 32-38
Authors:
YU EY
YU E
MEYER GE
BRAWER MK
Citation: Ey. Yu et al., THE RELATION OF P53 PROTEIN NUCLEAR ACCUMULATION AND ANGIOGENESIS IN HUMAN PROSTATIC-CARCINOMA, PROSTATE CANCER AND PROSTATIC DISEASES, 1(1), 1997, pp. 39-44